Britannia Life Sciences Inc.
BLAB
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.46M | 688.30K | 723.30K | 542.40K | 976.70K |
| Total Receivables | 158.70K | 792.10K | 1.24M | 1.12M | 892.80K |
| Inventory | -- | 135.00K | 144.20K | 136.20K | 136.20K |
| Prepaid Expenses | 17.00K | 13.30K | 20.30K | 25.30K | 9.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.27M | -- | -- | -- | -- |
| Total Current Assets | 6.91M | 1.63M | 2.13M | 1.83M | 2.02M |
|
|
|||||
| Total Current Assets | 6.91M | 1.63M | 2.13M | 1.83M | 2.02M |
| Net Property, Plant & Equipment | 99.50K | 427.40K | 489.50K | 497.10K | 532.70K |
| Long-term Investments | -- | 13.02M | 13.91M | 13.13M | 13.13M |
| Goodwill | -- | 13.02M | 13.91M | 13.13M | 13.13M |
| Total Other Intangibles | -- | 330.90K | 321.40K | 264.40K | 220.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.08M | 15.41M | 16.84M | 15.88M | 16.44M |
|
|
|||||
| Total Accounts Payable | 1.54M | 1.51M | 2.05M | 2.10M | 1.77M |
| Total Accrued Expenses | 863.00K | 1.02M | 541.30K | 275.80K | 449.70K |
| Short-term Debt | 20.40K | 19.80K | 21.10K | 107.60K | 108.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 119.60K | 1.69M | 1.74M | 1.59M | 1.54M |
| Total Finance Division Other Current Liabilities | -- | 3.86M | 4.12M | 3.90M | 3.90M |
| Total Other Current Liabilities | -- | 3.86M | 4.12M | 3.90M | 3.90M |
| Total Current Liabilities | 2.54M | 8.10M | 8.48M | 7.97M | 7.76M |
|
|
|||||
| Total Current Liabilities | 2.54M | 8.10M | 8.48M | 7.97M | 7.76M |
| Long-Term Debt | 1.07M | 3.07M | 3.54M | 3.13M | 3.52M |
| Short-term Debt | 20.40K | 19.80K | 21.10K | 107.60K | 108.60K |
| Capital Leases | 79.60K | 164.30K | 195.90K | 203.50K | 220.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 21.50K | 22.90K | 21.70K | 21.70K |
| Total Liabilities | 3.69M | 11.35M | 12.24M | 11.33M | 11.51M |
|
|
|||||
| Common Stock & APIC | 14.27M | 14.26M | 15.19M | 14.99M | 15.15M |
| Retained Earnings | -9.25M | -13.51M | -14.28M | -13.20M | -12.82M |
| Treasury Stock & Other | -644.80K | 68.50K | 220.70K | -393.30K | -528.10K |
| Total Common Equity | 4.38M | 821.40K | 1.12M | 1.39M | 1.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.38M | 821.40K | 1.12M | 1.39M | 1.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | 3.23M | 3.48M | 3.16M | 3.13M |
| Total Equity | 4.38M | 4.06M | 4.60M | 4.55M | 4.93M |
|
|
|||||